Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

Articles published in
N Engl J Med
    July 2024
  1. MEROLA JF, Cochran RL, Kroshinsky D, Prabhu M, et al
    Case 22-2024: A 30-Year-Old Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers.
    N Engl J Med. 2024;391:260-271.
    >> Share

  2. KOURNOUTAS I, Tung EE
    Yellow Nail Syndrome.
    N Engl J Med. 2024;391:68.
    >> Share

  3. PETERS NE, Mac Lochlainn DJ, Dhalla F, Howarth L, et al
    Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
    N Engl J Med. 2024;391:56-59.
    >> Share

  4. RIEDL MA, Farkas H, Aygoren-Pursun E, Psarros F, et al
    Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
    N Engl J Med. 2024;391:32-43.
    >> Share

  5. AMERATUNGA R, Longhurst HJ
    New Therapies for Type 1 and Type 2 Hereditary Angioedema.
    N Engl J Med. 2024;391:79-81.
    >> Share

  6. RIEDL MA, Tachdjian R, Lumry WR, Craig T, et al
    Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
    N Engl J Med. 2024;391:21-31.
    >> Share

    June 2024
  7. PLOTKIN SR, Yohay KH, Nghiemphu PL, Dinh CT, et al
    Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.
    N Engl J Med. 2024;390:2284-2294.
    >> Share

  8. SLAMON D, Yardley DA, Hortobagyi G
    Ribociclib plus Endocrine Therapy in Early Breast Cancer. Reply.
    N Engl J Med. 2024;390:2221-2222.
    >> Share

  9. TANNOCK IF, Meirson T, Fojo A
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220-2221.
    >> Share

  10. LI Q, Cai Y, Li J
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220.
    >> Share

  11. TU H, Zhang Y, You Z
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2219-2220.
    >> Share

  12. JORGE AM, Ard KL, Turbett SE
    Case 19-2024: A 46-Year-Old Man with Arthritis and Rash.
    N Engl J Med. 2024;390:2200-2207.
    >> Share

  13. ROY N, Mandal M
    Insulin-Induced Lipohypertrophy.
    N Engl J Med. 2024;390:e60.
    >> Share

  14. LONG GV, Hauschild A, Santinami M, Kirkwood JM, et al
    Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
    N Engl J Med. 2024 Jun 19. doi: 10.1056/NEJMoa2404139.
    >> Share

  15. WANG J, Liu J
    Tuberculosis Verrucosa Cutis.
    N Engl J Med. 2024;390:e58.
    >> Share

  16. MIDANI L, Ridgeway G, Phillips CM, Smidt AC, et al
    Inclusive Dermatology - Creating a Diverse Visual Atlas of Skin Conditions.
    N Engl J Med. 2024;390:2037-2038.
    >> Share

  17. VIDULA N, Rodriguez K, Wong AK, Boyraz B, et al
    Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer.
    N Engl J Med. 2024;390:2011-2022.
    >> Share

  18. BLANK CU, Lucas MW, Scolyer RA, van de Wiel BA, et al
    Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
    N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2402604.
    >> Share

    May 2024
  19. WECHSLER ME, Fan Y, Merkel PA
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
    N Engl J Med. 2024;390:1940.
    >> Share

  20. SUN R, Wei LJ
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:1939.
    >> Share

  21. DASKALAKIS DC, Heller HM, Shenoy ES, Hsu K, et al
    Case 16-2024: A 20-Year-Old Man with a Pustular Rash.
    N Engl J Med. 2024;390:1906-1912.
    >> Share

  22. KOWDLEY KV, Levy C, Jones D
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1935-1936.
    >> Share

  23. HIRSCHFIELD GM, Kremer AE, Levy C
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1934-1935.
    >> Share

  24. IJICHI H
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1934.
    >> Share

  25. AREVALO-CANAS C, Arevalo-Serrano J
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1933-1934.
    >> Share

  26. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    >> Share

  27. FEINSTEIN JA
    Learning to Say Goodbye.
    N Engl J Med. 2024;390:1742-1743.
    >> Share

  28. SAADOUN D, Bodaghi B, Cacoub P
    Behcet's Syndrome. Reply.
    N Engl J Med. 2024;390:1731-1732.
    >> Share

  29. IZZEDINE H, Jhaveri KD
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1731.
    >> Share

  30. PAMUK ON
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1730.
    >> Share

  31. FAMULARO G, Bracci M
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1730.
    >> Share

  32. AOKI K, Kojima M
    Polyarteritis Nodosa.
    N Engl J Med. 2024;390:1711.
    >> Share

    April 2024
  33. SPRAGUE S, O'Hara NN, Slobogean G
    Skin Antisepsis before Surgical Fracture Fixation. Reply.
    N Engl J Med. 2024;390:1533.
    >> Share

  34. SMOLLE MA, Puchwein P, Sadoghi P
    Skin Antisepsis before Surgical Fracture Fixation.
    N Engl J Med. 2024;390:1532-1533.
    >> Share

  35. YIN H, Lu L
    Evolution of Pyoderma Gangrenosum.
    N Engl J Med. 2024;390:e36.
    >> Share

  36. MARIN-ESTEBAN V, Molet L, Lagana M, Ciocan D, et al
    CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
    N Engl J Med. 2024;390:1339-1341.
    >> Share

  37. DE BONIFACE J, Filtenborg Tvedskov T, Ryden L, Szulkin R, et al
    Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
    N Engl J Med. 2024;390:1163-1175.
    >> Share

  38. MCGUIRE KP
    Axillary Dissection - The Bell Tolls for Thee.
    N Engl J Med. 2024;390:1231-1232.
    >> Share

    March 2024
  39. SLAMON D, Lipatov O, Nowecki Z, McAndrew N, et al
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:1080-1091.
    >> Share

  40. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    >> Share

    February 2024
  41. HIRSCHFIELD GM, Bowlus CL, Mayo MJ, Kremer AE, et al
    A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:783-794.
    >> Share

  42. CARLSON JCT, Sertic MM, Chen MY
    Case 6-2024: A 21-Year-Old Man with Fatigue and Night Sweats.
    N Engl J Med. 2024;390:747-756.
    >> Share

  43. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    >> Share

  44. MANSILLA POLO M, Martin-Torregrosa D
    Symmetric Drug-Related Intertriginous and Flexural Exanthema.
    N Engl J Med. 2024;390:e17.
    >> Share

  45. SAADOUN D, Bodaghi B, Cacoub P
    Behcet's Syndrome.
    N Engl J Med. 2024;390:640-651.
    >> Share

  46. GELFAND JM
    Psoriasis - More Progress but More Questions.
    N Engl J Med. 2024;390:561-562.
    >> Share

  47. TOVAR VETENCOURT A, Sayed-Ahmed I, Gomez J, Chen H, et al
    Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2024;390:530-535.
    >> Share

  48. BISSONNETTE R, Pinter A, Ferris LK, Gerdes S, et al
    An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.
    N Engl J Med. 2024;390:510-521.
    >> Share

  49. GALGIANI JN, Kauffman CA
    Coccidioidomycosis and Histoplasmosis in Immunocompetent Persons.
    N Engl J Med. 2024;390:536-547.
    >> Share

  50. STRONG N, Meeks G, Sheth SA, McCullough L, et al
    Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.
    N Engl J Med. 2024;390:522-529.
    >> Share

  51. LONGHURST HJ, Lindsay K, Petersen RS, Fijen LM, et al
    CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
    N Engl J Med. 2024;390:432-441.
    >> Share

  52. ROGERS SO JR, Wenzel RP
    Lister Revisited - Skin Antisepsis before Fracture Fixation.
    N Engl J Med. 2024;390:466-467.
    >> Share

  53. SPRAGUE S, Slobogean G, Wells JL, O'Hara NN, et al
    Skin Antisepsis before Surgical Fixation of Extremity Fractures.
    N Engl J Med. 2024;390:409-420.
    >> Share

    January 2024
  54. MOHAREB AM, Kang J, Montazeri K, Shroff SG, et al
    Case 2-2024: A 57-Year-Old Woman with Melanoma and Fever.
    N Engl J Med. 2024;390:255-265.
    >> Share

  55. ZHAO YK, Luo DQ
    Pubic Lice.
    N Engl J Med. 2024;390:e6.
    >> Share

  56. PATEL N, Shah H
    Exogenous Ochronosis from Skin-Lightening Cream.
    N Engl J Med. 2024;390:254.
    >> Share

  57. CHANTRAPITAK J, Chuamanochan M
    Papular-Purpuric "Gloves and Socks" Syndrome in Parvovirus B19 Infection.
    N Engl J Med. 2024;390:165.
    >> Share

  58. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    >> Share

    December 2023
  59. LAI JCT, Wu WKC, Chan WSA, Lau LHS, et al
    Case 39-2023: A 43-Year-Old Woman with Chronic Diarrhea, Hair Loss, and Nail and Skin Changes.
    N Engl J Med. 2023;389:2377-2385.
    >> Share

  60. ARJUNAN D, Bhadada SK
    Thyroid Dermopathy in Graves' Disease.
    N Engl J Med. 2023;389:2376.
    >> Share

    November 2023
  61. FOLLOWS AM, Follows GA
    Transverse Leukonychia (Mees' Lines).
    N Engl J Med. 2023;389:e48.
    >> Share

  62. WONG JCY, Li PH
    Large-Bowel Obstruction from Hereditary Angioedema.
    N Engl J Med. 2023;389:e41.
    >> Share

  63. KOWDLEY KV, Bowlus CL, Levy C, Akarca US, et al
    Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
    N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
    >> Share

  64. ZHAO M, Shen C
    Acrodermatitis Enteropathica.
    N Engl J Med. 2023;389:1803.
    >> Share

  65. WHELAN TJ, Parpia S, Levine MN
    Omitting Radiotherapy in Luminal A Breast Cancer. Reply.
    N Engl J Med. 2023;389:1727-1728.
    >> Share

  66. RECHT A
    Omitting Radiotherapy in Luminal A Breast Cancer.
    N Engl J Med. 2023;389:1727.
    >> Share

  67. PRADOS-CARMONA A, De la Torre Gomar FJ
    Acquired Reactive Perforating Collagenosis.
    N Engl J Med. 2023;389:e37.
    >> Share

    October 2023
  68. METZ M
    Targeting Interleukin-31 in Prurigo.
    N Engl J Med. 2023;389:1619-1620.
    >> Share

  69. LU H, Zhang B
    Mycoplasma-Induced Rash and Mucositis.
    N Engl J Med. 2023;389:1601.
    >> Share

  70. KWATRA SG, Yosipovitch G, Legat FJ, Reich A, et al
    Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
    N Engl J Med. 2023;389:1579-1589.
    >> Share

  71. HASSEL JC, Piperno-Neumann S, Rutkowski P, Baurain JF, et al
    Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
    N Engl J Med. 2023 Oct 21. doi: 10.1056/NEJMoa2304753.
    >> Share

  72. JANUSONYTE E, Punchera J
    Shiitake Dermatitis.
    N Engl J Med. 2023;389:1415.
    >> Share

  73. SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al
    Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    N Engl J Med. 2023;389:1263-1272.
    >> Share

  74. ALETAHA D
    Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    N Engl J Med. 2023;389:1328-1329.
    >> Share

  75. ONG EP, Ho FV
    Convalescent Rash of Dengue.
    N Engl J Med. 2023;389:e28.
    >> Share

    September 2023
  76. SCHMULTS CD
    Skin Cancer after Ruxolitinib or Belumosudil. Reply.
    N Engl J Med. 2023;389:1155.
    >> Share

  77. CUTLER C
    Skin Cancer after Ruxolitinib or Belumosudil.
    N Engl J Med. 2023;389:1154-1155.
    >> Share

  78. WANG WY, Cheng ST
    Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2023;389:1032.
    >> Share

  79. VOLPICELLI FM, Goldstein RH, Nussbaum EZ
    Case 28-2023: A 37-Year-Old Man with a Rash.
    N Engl J Med. 2023;389:1033-1039.
    >> Share

    August 2023
  80. SHANSHAL M, Ebadian M
    Serum Sickness.
    N Engl J Med. 2023;389:749.
    >> Share

  81. RAUCH DA, Victoria T, Pfeifer HH
    Case 25-2023: An 18-Year-Old Man with Fever and Foot Pain.
    N Engl J Med. 2023;389:643-651.
    >> Share

  82. WHELAN TJ, Smith S, Parpia S, Fyles AW, et al
    Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
    N Engl J Med. 2023;389:612-619.
    >> Share

  83. RAUWERDINK D, Balak D
    Burrow Ink Test for Scabies.
    N Engl J Med. 2023;389:e12.
    >> Share

  84. FANG WC, Chiu LW
    Neonatal Cephalic Pustulosis.
    N Engl J Med. 2023 Aug 5. doi: 10.1056/NEJMicm2301685.
    >> Share

    July 2023
  85. BARSHAK MB, Pineda R
    Case 14-2023: A Man with Redness of the Right Eye. Reply.
    N Engl J Med. 2023;389:383-384.
    >> Share

  86. KIERNAN M
    Case 14-2023: A Man with Redness of the Right Eye.
    N Engl J Med. 2023;389:383.
    >> Share

  87. SAID S, Blaser F
    Sectoral Heterochromia.
    N Engl J Med. 2023;389:e6.
    >> Share

  88. LEE GH, Guzman AK, Divito SJ, Soiffer RJ, et al
    Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil.
    N Engl J Med. 2023;389:188-190.
    >> Share

  89. SMITH TJ, Wang EJ, Loprinzi CL
    Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain.
    N Engl J Med. 2023;389:158-164.
    >> Share

  90. WOLKOW N, Romo LV, Edwards CV, Stagner AM, et al
    Case 21-2023: A 61-Year-Old Man with Eyelid Swelling.
    N Engl J Med. 2023;389:166-175.
    >> Share

  91. WANG X
    Inguinal Erythrasma.
    N Engl J Med. 2023;389:e4.
    >> Share

    June 2023
  92. ALLEN NC, Martin AJ, Damian DL
    Nicotinamide for Skin-Cancer Chemoprevention in Transplantation. Reply.
    N Engl J Med. 2023;388:2494-2495.
    >> Share

  93. TREPANOWSKI N, Kim DY, Hartman RI
    Nicotinamide for Skin-Cancer Chemoprevention in Transplantation.
    N Engl J Med. 2023;388:2493-2494.
    >> Share

  94. SCHMULTS CD, Jambusaria-Pahlajani A, Ruiz E
    Nicotinamide for Skin-Cancer Chemoprevention in Transplantation.
    N Engl J Med. 2023;388:2493.
    >> Share

  95. BERENGER JM, Parola P
    Pyemotes ventricosus Dermatitis.
    N Engl J Med. 2023;388:e80.
    >> Share

  96. BALWANI M, Desnick RJ, Belongie K
    Dersimelagon in Erythropoietic Protoporphyrias. Reply.
    N Engl J Med. 2023;388:2492-2493.
    >> Share

  97. BARMAN-AKSOZEN J, Langendonk JG
    Dersimelagon in Erythropoietic Protoporphyrias.
    N Engl J Med. 2023;388:2492.
    >> Share

  98. GRANATA F, Dechant C, Falchetto R
    Dersimelagon in Erythropoietic Protoporphyrias.
    N Engl J Med. 2023;388:2491-2492.
    >> Share

  99. LIU MJ, Li J
    Herpes Vegetans.
    N Engl J Med. 2023;388:2466.
    >> Share

  100. CHAPMAN L, Crotty GM
    Type I Cryoglobulinemic Vasculitis.
    N Engl J Med. 2023;388:2378.
    >> Share

  101. SILVERBERG JI, Guttman-Yassky E, Gontijo Lima R
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Reply.
    N Engl J Med. 2023;388:2299-2300.
    >> Share

  102. SMITH B, Engel P, Wu JJ
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023;388:2299.
    >> Share

  103. O'NEIL J, Kovach S
    Xylazine-Associated Skin Injury.
    N Engl J Med. 2023;388:2274.
    >> Share

  104. WYSONG A
    Squamous-Cell Carcinoma of the Skin.
    N Engl J Med. 2023;388:2262-2273.
    >> Share

  105. TURNER NC, Oliveira M, Howell SJ, Dalenc F, et al
    Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
    N Engl J Med. 2023;388:2058-2070.
    >> Share

    May 2023
  106. BAGHDASSARIAN H, Blackstone SA, Clay OS, Philips R, et al
    Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    N Engl J Med. 2023 May 31. doi: 10.1056/NEJMoa2202318.
    >> Share

  107. GOLDBERGER T, Armoni-Weiss G
    Miliaria Crystallina.
    N Engl J Med. 2023;388:e68.
    >> Share

  108. WEN L, Cai L
    Primary Diffuse Meningeal Melanomatosis.
    N Engl J Med. 2023;388:1892.
    >> Share

  109. BARSHAK MB, Dugdale CM, Pineda R
    Case 14-2023: A 31-Year-Old Man with Redness of the Right Eye.
    N Engl J Med. 2023;388:1800-1810.
    >> Share

  110. KOTHARI R, Khare S
    Dietary Zinc Deficiency-Associated Dermatitis in a Child.
    N Engl J Med. 2023;388:1799.
    >> Share

  111. GIORDANO SH
    POSITIVE Results for Breast Cancer Survivors Who Desire Pregnancy.
    N Engl J Med. 2023;388:1709-1710.
    >> Share

  112. PARTRIDGE AH, Niman SM, Ruggeri M, Peccatori FA, et al
    Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
    N Engl J Med. 2023;388:1645-1656.
    >> Share

    April 2023
  113. NAJJAR SN, Rezigh AB
    Dissecting Cellulitis of the Scalp.
    N Engl J Med. 2023;388:1608.
    >> Share

  114. BALWANI M, Bonkovsky HL, Levy C, Anderson KE, et al
    Dersimelagon in Erythropoietic Protoporphyrias.
    N Engl J Med. 2023;388:1376-1385.
    >> Share

  115. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    >> Share

  116. KATZ K
    Palmar Erythema of Pregnancy.
    N Engl J Med. 2023;388:e50.
    >> Share

    March 2023
  117. MANTECON L, Solis G
    Neonatal Herpes Simplex Virus Infection.
    N Engl J Med. 2023;388:1209.
    >> Share

  118. SHISHEHBOR MH, Powell RJ, Montero-Baker MF, Dua A, et al
    Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.
    N Engl J Med. 2023;388:1171-1180.
    >> Share

  119. TEKCAN SANLI DE, Kiziltas S
    Gastrointestinal Kaposi's Sarcoma.
    N Engl J Med. 2023;388:e45.
    >> Share

  120. AKHAM R, Hazarika N
    Paget's Disease of the Breast.
    N Engl J Med. 2023;388:1126.
    >> Share

  121. FREY SE, Goll JB, Beigel JH
    Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited.
    N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215846.
    >> Share

  122. WANG HJ, Hu SC
    Malignant Acanthosis Nigricans.
    N Engl J Med. 2023;388:1031.
    >> Share

  123. SILVERBERG JI, Guttman-Yassky E, Thaci D, Irvine AD, et al
    Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023 Mar 15. doi: 10.1056/NEJMoa2206714.
    >> Share

  124. MANSOUR MK, King JD, Chen ST, Fishman JA, et al
    Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
    N Engl J Med. 2023;388:926-937.
    >> Share

  125. FINAZZI A, Cosentini R
    Papulopustular Rash in Behcet's Disease.
    N Engl J Med. 2023;388:e30.
    >> Share

  126. MILLER DM, Emerick KS
    Skin-Cancer Chemoprevention in Transplant Recipients.
    N Engl J Med. 2023;388:844-846.
    >> Share

  127. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    >> Share

  128. PATEL SP, Othus M, Chen Y, Wright GP Jr, et al
    Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
    N Engl J Med. 2023;388:813-823.
    >> Share

  129. ALLEN NC, Martin AJ, Snaidr VA, Eggins R, et al
    Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    N Engl J Med. 2023;388:804-812.
    >> Share

  130. KUMAR M, Saifudeen AR
    Pseudoxanthoma Elasticum-like Syndrome.
    N Engl J Med. 2023;388:e26.
    >> Share

  131. ROHAAN MW, Kessels R, Haanen JBAG
    Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.
    N Engl J Med. 2023;388:859-860.
    >> Share

  132. LIM AR, Shin SW
    Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma.
    N Engl J Med. 2023;388:859.
    >> Share

    February 2023
  133. HO AY, Bellon JR
    Overcoming Resistance - Omission of Radiotherapy for Low-Risk Breast Cancer.
    N Engl J Med. 2023;388:652-653.
    >> Share

  134. KUNKLER IH, Williams LJ, Jack WJL, Cameron DA, et al
    Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.
    N Engl J Med. 2023;388:585-594.
    >> Share

  135. JIN J, Zhang Y
    Odontogenic Cutaneous Fistula.
    N Engl J Med. 2023;388:543.
    >> Share

  136. KIM BS, Bissonnette R, Nograles K, Munera C, et al
    Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
    N Engl J Med. 2023;388:511-517.
    >> Share

  137. DOSHI KB
    Calloused, Hyperpigmented Fingertips.
    N Engl J Med. 2023;388:e14.
    >> Share

    January 2023
  138. KAKURAI M, Oya K
    Atopic Eruption of Pregnancy.
    N Engl J Med. 2023;388:357.
    >> Share

  139. ROSMARIN D, Kornacki D, Ezzedine K
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply.
    N Engl J Med. 2023;388:284.
    >> Share

  140. JANSSEN JC, Mulder EEAP, van der Veldt AAM
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
    N Engl J Med. 2023;388:283.
    >> Share

  141. TANG B, Chang X
    Condylomata Lata.
    N Engl J Med. 2023;388:e3.
    >> Share

  142. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    >> Share

  143. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    >> Share

    December 2022
  144. MAALOUF NS, Morand M
    Serpentine Supravenous Hyperpigmentation.
    N Engl J Med. 2022;387:e67.
    >> Share

  145. PAYNE AS
    Topical Gene Therapy for Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2281-2284.
    >> Share

  146. SCHAFFER DV
    The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2279-2280.
    >> Share

  147. GUIDE SV, Gonzalez ME, Bagci IS, Agostini B, et al
    Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2211-2219.
    >> Share

  148. VIEDMA-MARTINEZ M, Villegas Romero I
    Skin Necrosis after Transarterial Chemoembolization.
    N Engl J Med. 2022;387:2268.
    >> Share

  149. CHARI A, Minnema MC, Berdeja JG, Oriol A, et al
    Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
    N Engl J Med. 2022;387:2232-2244.
    >> Share

  150. ROHAAN MW, Borch TH, van den Berg JH, Met O, et al
    Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2022;387:2113-2125.
    >> Share

  151. LANG DM
    Chronic Urticaria. Reply.
    N Engl J Med. 2022;387:2103.
    >> Share

  152. ROLLA G
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102-2103.
    >> Share

  153. WEINBERGER M
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102.
    >> Share

  154. BONNIN AJ
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101-2102.
    >> Share

  155. DESCAMPS V
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101.
    >> Share

    November 2022
  156. ZHOU HY, Liu ZH
    Pyoderma Gangrenosum.
    N Engl J Med. 2022;387:e48.
    >> Share

    October 2022
  157. COHEN EM, Sobrin L, Figueiro Longo MG, Pier DB, et al
    Case 33-2022: An 11-Year-Old Girl with Redness of the Eyes.
    N Engl J Med. 2022;387:1598-1607.
    >> Share

  158. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    >> Share

  159. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    >> Share

  160. EIDSMO L
    New Hope for Patients with Vitiligo.
    N Engl J Med. 2022;387:1515-1516.
    >> Share

  161. DESAI AS, Dudzinski DM, Stib MT, Chen ST, et al
    Case 32-2022: A 76-Year-Old Man with Postoperative Cardiogenic Shock and Diffuse Rash.
    N Engl J Med. 2022;387:1502-1513.
    >> Share

  162. LEE JB, Schwartz Z
    Tinea Nigra.
    N Engl J Med. 2022;387:1501.
    >> Share

  163. ROSMARIN D, Passeron T, Pandya AG, Grimes P, et al
    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
    N Engl J Med. 2022;387:1445-1455.
    >> Share

  164. CORTES J, Zhou X, Schmid P
    Pembrolizumab in Triple-Negative Breast Cancer. Reply.
    N Engl J Med. 2022;387:1436.
    >> Share

  165. ALTUNDAG K
    Pembrolizumab in Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:1435-1436.
    >> Share

  166. SUN R, Wei LJ
    Pembrolizumab in Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:1435.
    >> Share

  167. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    >> Share

  168. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    >> Share

  169. KHAITAN BK, Ahuja R
    Erythema Ab Igne.
    N Engl J Med. 2022;387:e33.
    >> Share

  170. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    >> Share

    September 2022
  171. MODI S, Gambhire D, Cameron D
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Reply.
    N Engl J Med. 2022;387:1145-1146.
    >> Share

  172. CARROLL HK, Higgins MJ, O'Reilly S
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer.
    N Engl J Med. 2022;387:1144.
    >> Share

  173. SCHNOG JB, Samson MJ, Duits AJ
    Trastuzumab Deruxtecan in HER2-Low Breast Cancer.
    N Engl J Med. 2022;387:1143-1144.
    >> Share

  174. GROSS ND, Miller DM, Khushalani NI, Divi V, et al
    Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
    N Engl J Med. 2022 Sep 12. doi: 10.1056/NEJMoa2209813.
    >> Share

  175. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

  176. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    >> Share

    August 2022
  177. CHRISTIAN NT, Borges VF
    What Dobbs Means for Patients with Breast Cancer.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2209249.
    >> Share

  178. SOUMERAI JD
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply.
    N Engl J Med. 2022;387:763-764.
    >> Share

  179. FAJGENBAUM DC
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply.
    N Engl J Med. 2022;387:763.
    >> Share

  180. VAN RHEE F
    Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass.
    N Engl J Med. 2022;387:762-763.
    >> Share

  181. ZOSHIMA T, Kawano M
    Tongue Telangiectasias in Systemic Sclerosis.
    N Engl J Med. 2022;387:737.
    >> Share

  182. KAHN M, Fleece M
    Rice Bodies in Tenosynovitis Due to Psoriatic Arthritis.
    N Engl J Med. 2022;387:e14.
    >> Share

  183. ZHANG W, Zhang ZL
    Lupus Pernio in Sarcoidosis.
    N Engl J Med. 2022;387:546.
    >> Share

    July 2022
  184. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    >> Share

  185. BOYCE M, Flower C
    Tripe Palms.
    N Engl J Med. 2022;387:355.
    >> Share

  186. PIVOT X
    Pembrolizumab in the Treatment of Breast Cancer.
    N Engl J Med. 2022;387:273-274.
    >> Share

  187. CORTES J, Rugo HS, Cescon DW, Im SA, et al
    Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:217-226.
    >> Share

  188. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    >> Share

  189. HUNG WK, Chung WH
    Drug Reaction with Eosinophilia and Systemic Symptoms.
    N Engl J Med. 2022;387:167.
    >> Share

  190. HURVITZ SA
    DESTINY-Changing Results for Advanced Breast Cancer.
    N Engl J Med. 2022;387:75-76.
    >> Share

    June 2022
  191. JATOI I, Sung H, Jemal A
    The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality.
    N Engl J Med. 2022;386:2349-2352.
    >> Share

  192. ROKHZAN R, Meier K
    Targeted Therapy in Melanoma.
    N Engl J Med. 2022;386:e66.
    >> Share

  193. CORTES J, Im SA, Cathcart J
    Trastuzumab Deruxtecan for Breast Cancer. Reply.
    N Engl J Med. 2022;386:2347.
    >> Share

  194. ZHENG F, Du F, Yuan P
    Trastuzumab Deruxtecan for Breast Cancer.
    N Engl J Med. 2022;386:2346-2347.
    >> Share

  195. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    >> Share

  196. MODI S, Jacot W, Yamashita T, Sohn J, et al
    Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
    N Engl J Med. 2022 Jun 5. doi: 10.1056/NEJMoa2203690.
    >> Share

    May 2022
  197. FAJGENBAUM DC, Goiffon RJ, Soumerai JD, Harris CK, et al
    Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal Mass.
    N Engl J Med. 2022;386:2036-2048.
    >> Share

  198. TAWBI HA, Hodi FS, Long GV
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply.
    N Engl J Med. 2022;386:1860-1861.
    >> Share

  199. HINDIE E
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:1860.
    >> Share

  200. ALHATEM A, Smith KC
    Primary Cutaneous Blastomycosis.
    N Engl J Med. 2022;386:e49.
    >> Share

  201. SCHMID P, Cortes J, Dent R
    Pembrolizumab in Early Triple-Negative Breast Cancer. Reply.
    N Engl J Med. 2022;386:1771-1772.
    >> Share

  202. GANGULY S, Gogia A
    Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:1771.
    >> Share

  203. MESSENGER A, Harries M
    Baricitinib in Alopecia Areata.
    N Engl J Med. 2022;386:1751-1752.
    >> Share

  204. KING B, Ohyama M, Kwon O, Zlotogorski A, et al
    Two Phase 3 Trials of Baricitinib for Alopecia Areata.
    N Engl J Med. 2022;386:1687-1699.
    >> Share

    April 2022
  205. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    >> Share

    March 2022
  206. CORTES J, Kim SB, Chung WP, Im SA, et al
    Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
    N Engl J Med. 2022;386:1143-1154.
    >> Share

  207. ZHANG P, Chen L
    Melanoma of the Palpebral Conjunctiva and Eyelid.
    N Engl J Med. 2022 Mar 19. doi: 10.1056/NEJMicm2115699.
    >> Share

  208. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    >> Share

  209. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    >> Share

  210. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    >> Share

  211. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    >> Share

  212. ALAGESAN M, Chidambaram Y
    Pellagra.
    N Engl J Med. 2022;386:e24.
    >> Share

  213. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
    Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
    N Engl J Med. 2022;386:942-950.
    >> Share

    February 2022
  214. LEUNG TH, Cotsarelis G
    Cellular Memories - More Than Skin Deep.
    N Engl J Med. 2022;386:793-795.
    >> Share

  215. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    >> Share

  216. SCHMID P, Cortes J, Dent R, Pusztai L, et al
    Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:556-567.
    >> Share

  217. YOKOYAMA T
    Chronic Generalized Pruritus.
    N Engl J Med. 2022;386:e12.
    >> Share

  218. BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
    Calm before the Storm.
    N Engl J Med. 2022;386:479-485.
    >> Share

    January 2022
  219. GRAYSON PC, Perugino CA, Dinculescu VV, Ferry JA, et al
    Case 2-2022: A 70-Year-Old Man with a Recurrent Left Pleural Effusion.
    N Engl J Med. 2022;386:274-283.
    >> Share

  220. MAHARAJH S, Teelucksingh S
    Hyperpigmentation in Vitamin B12 Deficiency.
    N Engl J Med. 2022;386:172.
    >> Share

  221. FRAMPTON AE, Sivakumar S
    A New Combination Immunotherapy in Advanced Melanoma.
    N Engl J Med. 2022;386:91-92.
    >> Share

  222. TAWBI HA, Schadendorf D, Lipson EJ, Ascierto PA, et al
    Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:24-34.
    >> Share

  223. JOHN LN, Beiras CG, Houinei W, Medappa M, et al
    Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.
    N Engl J Med. 2022;386:47-56.
    >> Share

    December 2021
  224. SHARMA V, Kumar A
    Carcinoma en Cuirasse.
    N Engl J Med. 2021;385:2562.
    >> Share

  225. BACHELEZ H, Choon SE, Marrakchi S, Burden AD, et al
    Trial of Spesolimab for Generalized Pustular Psoriasis.
    N Engl J Med. 2021;385:2431-2440.
    >> Share

  226. KATAYAMA S, Ota M
    Minocycline-Induced Hyperpigmentation.
    N Engl J Med. 2021;385:2463.
    >> Share

  227. KALINSKY K, Barlow WE, Gralow JR, Meric-Bernstam F, et al
    21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
    N Engl J Med. 2021;385:2336-2347.
    >> Share

  228. WILLETT LL, Bromberg GK, Chung R, Leaf RK, et al
    Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    N Engl J Med. 2021;385:2378-2388.
    >> Share

  229. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    >> Share

  230. MCKINLEY TD, Maroon M
    Linear Darier's Disease.
    N Engl J Med. 2021;385:e91.
    >> Share

  231. BIEBER T
    AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis.
    N Engl J Med. 2021;385:2295-2296.
    >> Share

  232. LEBWOHL MG, Stein Gold L, Strober B, Papp KA, et al
    Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
    N Engl J Med. 2021;385:2219-2229.
    >> Share

  233. KUECKELHAUS M, Rothoeft T, De Rosa L, Yeni B, et al
    Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
    N Engl J Med. 2021;385:2264-2270.
    >> Share

  234. WALLACE ZS, Rodriguez K, Dau J, Bloch DB, et al
    Case 37-2021: A 60-Year-Old Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash.
    N Engl J Med. 2021;385:2282-2293.
    >> Share

  235. KALLESH A, Kumar VS
    Congenital Langerhans-Cell Histiocytosis.
    N Engl J Med. 2021;385:e86.
    >> Share

    November 2021
  236. WINSTON LG, Winkler ML, Kheterpal A, Villalba JA, et al
    Case 36-2021: A 22-Year-Old Man with Pain and Erythema of the Left Hand.
    N Engl J Med. 2021;385:2078-2086.
    >> Share

  237. WANG T, Chen JQ
    Tinea Capitis Due to Microsporum canis.
    N Engl J Med. 2021;385:2077.
    >> Share

  238. VARONI EM, Decani S
    Gingival Melanoma.
    N Engl J Med. 2021;385:e73.
    >> Share

  239. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    >> Share

    October 2021
  240. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    >> Share

  241. AKINTILO L, Femia A
    Disseminated Cryptococcosis.
    N Engl J Med. 2021;385:1699.
    >> Share

  242. RAMIREZ-LLUCH M, Hernandez-Martin A
    Pearly Penile Papules.
    N Engl J Med. 2021;385:1420.
    >> Share

  243. TUTT ANJ, Garber JE, Geyer CE Jr
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply.
    N Engl J Med. 2021;385:1440.
    >> Share

  244. HOSHI A, Bando H, Sekine I
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439-1440.
    >> Share

  245. NOZAWA K, Yoshimura A, Iwata H
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439.
    >> Share

    September 2021
  246. LINDSAY ME, Dudzinski DM, Yoon BC, Jaff MR, et al
    Case 30-2021: A 47-Year-Old Man with Recurrent Unilateral Head and Neck Pain.
    N Engl J Med. 2021;385:1317-1325.
    >> Share

  247. BARRY D, Schmieder A
    Leukemia Cutis.
    N Engl J Med. 2021;385:1316.
    >> Share

  248. BOSE R, Ma CX
    Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.
    N Engl J Med. 2021;385:1241-1243.
    >> Share

  249. TSUI JC, Onishi S
    Symblepharon in Linear IgA Bullous Dermatosis.
    N Engl J Med. 2021;385:1219.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016